View multimedia release here. Rye Brook, N.Y. (Aug. 7, 2018) — As costs for cancer care skyrocket – projected to be $173 billion by 2020, a 39 percent increase from 2010 – The Leukemia & Lymphoma Society® (LLS) is renewing its call for action to ease the cost of cancer care for patients. Today, LLS released a national “Progress Report on the Cost of Cancer Care,” a review of policy measures tak...
Rye Brook, N.Y. (July 20, 2018) – Progress in treating acute myeloid leukemia (AML), a blood cancer that takes more than 10,000 lives in the United States each year, took an important step forward today with the U.S. Food & Drug Administration (FDA) approval of ivosidenib (Tibsovo®) for patients who have a specific genetic mutation called IDH1. The Leukemia & Lymphoma Society (LLS), a leader i...
(Rye Brook, NY, July 10, 2018) - The Leukemia & Lymphoma Society (LLS) announced today five new appointments to its board of directors, including four influential research scientists; Casey Cunningham, M.D., Christopher Flowers, M.D., Janice L. Gabrilove, M.D. and Ruben A. Mesa, M.D. Their appointments build strength in the diagnosis and treatment of lymphoma and myeloproliferative neoplasms as well as methods fo...
View multimedia release here. Rye Brook, NY (July 9, 2018) – In a spirited philanthropic competition to raise the most money for cancer cures in a 10-week timeframe, dedicated community leaders and their teams of supporters in cities across the country volunteered their time, skills, energy and passion to compete for the prestigious national title of The Leukemia & Lymphoma Society’s (LLS) Man & W...
Have media inquiries? Contact us between 9 a.m. and 5 p.m. ET, Monday through Friday: